Teva Pharmaceuticals?A Market Leader

In the generic pharmaceutical market, Teva Pharmaceuticals (North Wales, PA) is the leader without peer, ranking number one in prescriptions filled, sales dollars, Abbreviated New Drug Application (ANDA) filings including first-to-files, product launches, breadth of product line, vertical integration, pedigree technology, and many other criteria.

Teva now has more than 28,000 employees and annual sales that totaled $9.4 billion in 2007. Over the last few years, Teva has added diversity and depth to its product line, pipeline, and geographic markets; expanded its reach in the primary distribution channels; and added new product specialties.

Teva Health Systems (THS), the division of Teva focused on institutional segments, is quickly building a dominant position of its own. By structuring a sales approach that leverages everything Teva has in its vast existing portfolio of oral and injectable formulations, together with the most productive product pipeline in the industry, THS has established itself as a major player in the market.

Teva has a well-established and balanced portfolio of products that customers want, and a strong active pharmaceutical ingredient business to meet their needs. In addition, a vertically integrated structure ensures that as the company continues to grow, Teva can maintain its high standard of quality and its longstanding commitment to customer satisfaction. With more than 300 products and 1000 SKUs, Teva is able to respond to the wide range of needs of patients, customers, and health care providers, both therapeutically and economically.